237 related articles for article (PubMed ID: 28685158)
1. Imaging tau pathology in Parkinsonisms.
Coakeley S; Strafella AP
NPJ Parkinsons Dis; 2017; 3():22. PubMed ID: 28685158
[TBL] [Abstract][Full Text] [Related]
2. Imaging pathological tau in atypical parkinsonisms: A review.
Mena AM; Strafella AP
Clin Park Relat Disord; 2022; 7():100155. PubMed ID: 35880206
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of [
Tezuka T; Takahata K; Seki M; Tabuchi H; Momota Y; Shiraiwa M; Suzuki N; Morimoto A; Nakahara T; Iwabuchi Y; Miura E; Yamamoto Y; Sano Y; Funaki K; Yamagata B; Ueda R; Yoshizaki T; Mashima K; Shibata M; Oyama M; Okada K; Kubota M; Okita H; Takao M; Jinzaki M; Nakahara J; Mimura M; Ito D
Brain Commun; 2021; 3(4):fcab190. PubMed ID: 34632382
[TBL] [Abstract][Full Text] [Related]
4. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.
Ono M; Sahara N; Kumata K; Ji B; Ni R; Koga S; Dickson DW; Trojanowski JQ; Lee VM; Yoshida M; Hozumi I; Yoshiyama Y; van Swieten JC; Nordberg A; Suhara T; Zhang MR; Higuchi M
Brain; 2017 Mar; 140(3):764-780. PubMed ID: 28087578
[TBL] [Abstract][Full Text] [Related]
5. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.
Marquié M; Normandin MD; Vanderburg CR; Costantino IM; Bien EA; Rycyna LG; Klunk WE; Mathis CA; Ikonomovic MD; Debnath ML; Vasdev N; Dickerson BC; Gomperts SN; Growdon JH; Johnson KA; Frosch MP; Hyman BT; Gómez-Isla T
Ann Neurol; 2015 Nov; 78(5):787-800. PubMed ID: 26344059
[TBL] [Abstract][Full Text] [Related]
6. Tau Imaging in Parkinsonism: What Have We Learned So Far?
Whitwell JL
Mov Disord Clin Pract; 2018; 5(2):118-130. PubMed ID: 30035155
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.
Holland N; Malpetti M; Rittman T; Mak EE; Passamonti L; Kaalund SS; Hezemans FH; Jones PS; Savulich G; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
Brain; 2022 Mar; 145(1):340-348. PubMed ID: 34398211
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography imaging of tau pathology in progressive supranuclear palsy.
Coakeley S; Cho SS; Koshimori Y; Rusjan P; Harris M; Ghadery C; Kim J; Lang AE; Wilson A; Houle S; Strafella AP
J Cereb Blood Flow Metab; 2017 Sep; 37(9):3150-3160. PubMed ID: 28155586
[TBL] [Abstract][Full Text] [Related]
9. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
10. [
Whitwell JL; Lowe VJ; Tosakulwong N; Weigand SD; Senjem ML; Schwarz CG; Spychalla AJ; Petersen RC; Jack CR; Josephs KA
Mov Disord; 2017 Jan; 32(1):124-133. PubMed ID: 27787958
[TBL] [Abstract][Full Text] [Related]
11. An autoradiographic evaluation of AV-1451 Tau PET in dementia.
Lowe VJ; Curran G; Fang P; Liesinger AM; Josephs KA; Parisi JE; Kantarci K; Boeve BF; Pandey MK; Bruinsma T; Knopman DS; Jones DT; Petrucelli L; Cook CN; Graff-Radford NR; Dickson DW; Petersen RC; Jack CR; Murray ME
Acta Neuropathol Commun; 2016 Jun; 4(1):58. PubMed ID: 27296779
[TBL] [Abstract][Full Text] [Related]
12. Tau imaging with [
Ishiki A; Harada R; Okamura N; Tomita N; Rowe CC; Villemagne VL; Yanai K; Kudo Y; Arai H; Furumoto S; Tashiro M; Furukawa K
Eur J Neurol; 2017 Jan; 24(1):130-136. PubMed ID: 27797445
[TBL] [Abstract][Full Text] [Related]
13. An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with
Tagai K; Ikoma Y; Endo H; Debnath OB; Seki C; Matsuoka K; Matsumoto H; Oya M; Hirata K; Shinotoh H; Takahata K; Kurose S; Sano Y; Ono M; Shimada H; Kawamura K; Zhang MR; Takado Y; Higuchi M
Neuroimage; 2022 Dec; 264():119763. PubMed ID: 36427751
[TBL] [Abstract][Full Text] [Related]
14. High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies.
Tagai K; Ono M; Kubota M; Kitamura S; Takahata K; Seki C; Takado Y; Shinotoh H; Sano Y; Yamamoto Y; Matsuoka K; Takuwa H; Shimojo M; Takahashi M; Kawamura K; Kikuchi T; Okada M; Akiyama H; Suzuki H; Onaya M; Takeda T; Arai K; Arai N; Araki N; Saito Y; Trojanowski JQ; Lee VMY; Mishra SK; Yamaguchi Y; Kimura Y; Ichise M; Tomita Y; Zhang MR; Suhara T; Shigeta M; Sahara N; Higuchi M; Shimada H
Neuron; 2021 Jan; 109(1):42-58.e8. PubMed ID: 33125873
[TBL] [Abstract][Full Text] [Related]
15. Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.
Marquié M; Normandin MD; Meltzer AC; Siao Tick Chong M; Andrea NV; Antón-Fernández A; Klunk WE; Mathis CA; Ikonomovic MD; Debnath M; Bien EA; Vanderburg CR; Costantino I; Makaretz S; DeVos SL; Oakley DH; Gomperts SN; Growdon JH; Domoto-Reilly K; Lucente D; Dickerson BC; Frosch MP; Hyman BT; Johnson KA; Gómez-Isla T
Ann Neurol; 2017 Jan; 81(1):117-128. PubMed ID: 27997036
[TBL] [Abstract][Full Text] [Related]
16. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
[TBL] [Abstract][Full Text] [Related]
17. Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias.
Wren MC; Lashley T; Årstad E; Sander K
Acta Neuropathol Commun; 2018 May; 6(1):34. PubMed ID: 29716656
[TBL] [Abstract][Full Text] [Related]
18. [
Marquié M; Agüero C; Amaral AC; Villarejo-Galende A; Ramanan P; Chong MST; Sáez-Calveras N; Bennett RE; Verwer EE; Kim SJW; Dhaynaut M; Alvarez VE; Johnson KA; McKee AC; Frosch MP; Gómez-Isla T
Acta Neuropathol Commun; 2019 Oct; 7(1):164. PubMed ID: 31661038
[TBL] [Abstract][Full Text] [Related]
19. Characterization of tau positron emission tomography tracer [
Sander K; Lashley T; Gami P; Gendron T; Lythgoe MF; Rohrer JD; Schott JM; Revesz T; Fox NC; Årstad E
Alzheimers Dement; 2016 Nov; 12(11):1116-1124. PubMed ID: 26892233
[TBL] [Abstract][Full Text] [Related]
20. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.
Okamura N; Furumoto S; Harada R; Tago T; Yoshikawa T; Fodero-Tavoletti M; Mulligan RS; Villemagne VL; Akatsu H; Yamamoto T; Arai H; Iwata R; Yanai K; Kudo Y
J Nucl Med; 2013 Aug; 54(8):1420-7. PubMed ID: 23857514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
